Carlsmed, Inc., a San Diego, CA-based MedTech company, closed a $2.5M seed funding round.
The round was led by Cove Fund II, with participation from Wavemaker Three-Sixty Health and Device of Tomorrow Capital, as well as individual MedTech investors.
The company intends to use the funds for the clinical launch of the aprevo™ system.
Led by Mike Cordonnier, CEO and co-founder, and newly appointed Alexander Arrow, MD, CFA, Chief Financial Officer, and Shariq Hussain, Chief Information Officer, Carlsmed is leveraging Machine Learning technologies and prior outcomes data to personalize the treatment of complex adult spinal deformities. The company’s proprietary aprevo system makes surgical plans and devices tailored to the precise medical situation of every individual patient. Carlsmed is currently incubating at EvoNexus, California’s non-profit startup technology incubator.